Showing results (1691-1700 of 1,707) with videos related to

Sort By:
Pageof 171
The American Journal of Gastroenterology|June 28, 2018
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumNeeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The Lancet. Gastroenterology & Hepatology|April 19, 2021
Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease GroupBo Shen, Gursimran S Kochhar, Udayakumar Navaneethan, et al.
Signal Transduction and Targeted Therapy|January 20, 2022
Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunctionZhen Wang, Fan-Lian Zeng, Ya-Wen Hu, et al.
The American Journal of Gastroenterology|November 4, 2018
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumNeeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The Lancet. Gastroenterology & Hepatology|November 14, 2021
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch ConsortiumBo Shen, Gursimran S Kochhar, David T Rubin, et al.
The Lancet. Gastroenterology & Hepatology|August 20, 2021
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch ConsortiumBo Shen, Gursimran S Kochhar, Revital Kariv, et al.
American Journal of Translational Research|May 2, 2020
Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgGBo Shen, Yufen Zheng, Xiaoyan Zhang, et al.
Gastroenterology|June 2, 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's DiseaseParambir S Dulai, Brigid S Boland, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2020
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative ColitisParambir S Dulai, Siddharth Singh, Niels Vande Casteele, et al.
Pageof 171